Rocket Lab Corp Chief Financial Officer Adam C. Spice reported open-market sales of 62,744 shares of Common Stock on May 26, 2026. The shares were sold in multiple trades at weighted-average prices ranging from $138.7700 to $144.7600 per share.
According to the disclosure, these transactions were executed as a sell-to-cover arrangement under a pre-established Rule 10b5-1 election to satisfy tax withholding obligations tied to vesting and settlement of previously granted restricted stock units. Following the sales, Spice directly holds 983,049 shares and indirectly holds 250,000 shares through a trust.
Rocket Lab Corp director and CEO Peter Beck reported an indirect conversion by a family trust associated with him. On May 26, 2026, the Equatorial Trust converted 5,000,000 shares of Series A Convertible Participating Preferred Stock into 5,000,000 shares of Common Stock at a stated price of $0.0000 per share, held indirectly "by Trust."
The filing notes that the Trust made this optional conversion to satisfy delivery of Common Stock for sales to be made in future months under a Rule 10b5-1 Plan adopted on March 27, 2026, indicating the sales are pre-planned. After the transaction, the Trust still holds 40,951,250 shares of the preferred stock and 5,000,000 shares of Common Stock indirectly, while Beck also holds 491,930 shares of Common Stock directly. The filing states that Beck disclaims beneficial ownership of the Trust-held securities except to the extent of his pecuniary interest.
Rocket Lab Corp Chief Operations Officer Frank Klein sold 44,390 shares of common stock in open-market transactions on May 26, 2026. The filing states these sales were part of a Rule 10b5-1 “sell-to-cover” plan to satisfy tax withholding from vested restricted stock units, and he continues to hold more than 1 million shares afterward.
Rocket Lab Corp senior vice president and general counsel Arjun Kampani reported open-market sales of company common stock to cover taxes tied to equity compensation. He sold a total of 98,668 shares on May 26–27, 2026 pursuant to a pre-arranged Rule 10b5-1 "sell-to-cover" election for tax withholding on vested restricted stock units. Trade prices were reported as weighted-average figures for multiple executions, including $150.0000 and $139.4122 per share. Following these transactions, Kampani directly holds 376,509 shares of Rocket Lab common stock.
Rocket Lab Corp executive Marvin Bradford Clevenger, President of Rocket Lab USA, Inc, reported selling 15,549 shares of common stock on May 26, 2026. The six open-market sales occurred at weighted-average prices between about 139 and 144 per share.
According to the disclosure, these transactions were a sell-to-cover event to satisfy tax withholding obligations triggered by the vesting and settlement of previously granted restricted stock units. The filing notes that additional shares were recently acquired under Rocket Lab’s 2021 Employee Stock Purchase Plan in exempt transactions.
RKLB notice: 23,804 shares of Common Stock are identified for sale pursuant to Rule 144 as restricted stock units dated 05/22/2026.
The filing lists prior sales by Arjun Kampani during March–May 2026 (examples: 60,900 shares on 05/27/2026 for $8,793,783.39; 28,668 shares on 05/26/2026 for $4,087,297.10). The form reports Morgan Stanley Smith Barney LLC as the broker.
RKLB filing reports proposed sale of 36,860 shares of Common Stock tied to Restricted Stock Units by the issuer on 05/22/2026. The excerpt also lists three recent dispositions by Frank Klein: 44,390, 36,768, and 44,482 shares on 05/26/2026, 03/04/2026, and 03/01/2026 respectively, with dollar values shown for each sale.
Issuer submitted a Form 144 reporting proposed resale of 3,500 shares of Common Stock on 05/22/2026 tied to restricted stock vesting under a registered plan. The filing also lists prior sales by Marvin Bradford Clevenger of 14,622 shares ($2,084,709.72) and 927 shares ($132,165.63) on 05/22/2026.
RKLB filed a Form 144 reporting proposed sales of Common Stock by Arjun Kampani. The filing lists transactions on 03/04/2026 and 03/02/2026 including a sale of 23,711 shares for $1,704,714.27 on 03/04/2026 and multiple dispositions on 03/02/2026 (for example, 16,792 shares for $1,175,965.59 and 5,284 shares for $365,142.37). The filing also shows earlier restricted stock vesting entries under a registered plan dated 03/13/2025, 08/22/2024, and 11/22/2024.
Rocket Lab Corp reported proposed resale activity on a Form 144 filed 05/27/2026. The filing shows 9,100 shares associated with Fidelity Brokerage Services LLC tied to a stock award (compensation) dated 08/22/2023. The filing also lists recent sales by Arjun L. Kampani: 28,761 shares on 03/02/2026 for $2,001,474.42 and 23,711 shares on 03/04/2026 for $1,662,852.43.